BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6111350)

  • 1. Inactivation of pyroglutamyl aminopeptidase by L-pyroglutamyl chloromethyl ketone.
    Fujiwara K; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1981 Mar; 658(1):10-6. PubMed ID: 6111350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of pyroglutamyl aminopeptidase by N alpha-carbobenzoxy-L-pyroglutamyl chloromethyl ketone.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    J Biochem; 1981 Aug; 90(2):433-7. PubMed ID: 6117551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-alpha-carbobenzoxy pyroglutamyl diazomethyl ketone as active-site-directed inhibitor for pyroglutamyl peptidase.
    Fujiwara K; Matsumoto E; Kitagawa T; Tsuru D
    Biochim Biophys Acta; 1982 Apr; 702(2):149-54. PubMed ID: 6123347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroglutamyl diazomethyl ketone: potent inhibitor of mammalian pyroglutamyl peptide hydrolase.
    Wilk S; Friedman TC; Kline TB
    Biochem Biophys Res Commun; 1985 Jul; 130(2):662-8. PubMed ID: 2862865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of a particulate thyrotropin-releasing hormone-degrading enzyme in rat brain by the use of specific inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase.
    Friedman TC; Wilk S
    J Neurochem; 1986 Apr; 46(4):1231-9. PubMed ID: 2869108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase.
    Bundgaard H; Møss J
    J Pharm Sci; 1989 Feb; 78(2):122-6. PubMed ID: 2565975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
    Friedman TC; Wilk S
    Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase.
    Friedman TC; Kline TB; Wilk S
    Biochemistry; 1985 Jul; 24(15):3907-13. PubMed ID: 2864952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain.
    Charli JL; Mendez M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1987; 9(4):373-8. PubMed ID: 2886950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.
    Kupfer A; Gani V; Jiménez JS; Shaltiel S
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3073-7. PubMed ID: 226953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of some substrates and potential inhibitors of tissue pyroglutamyl aminopeptidase I.
    Svoboda KS; Currie BL
    Neuropeptides; 1992 Feb; 21(2):85-92. PubMed ID: 1348354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of a thyrotropin-releasing hormone-degrading enzyme in GH3 cells: induction of pyroglutamyl peptidase I by 3,5,3'-triiodothyronine.
    Suen CS; Wilk S
    Endocrinology; 1987 Aug; 121(2):770-5. PubMed ID: 2885183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone.
    Bauer K; Nowak P; Kleinkauf H
    Eur J Biochem; 1981 Aug; 118(1):173-6. PubMed ID: 6116600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New chromogenic and fluorogenic substrates for pyrrolidonyl peptidase.
    Fujiwara K; Tsuru D
    J Biochem; 1978 Apr; 83(4):1145-9. PubMed ID: 26673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.
    Charli JL; Mendez M; Vargas MA; Cisneros M; Assai M; Joseph-Bravo P; Wilk S
    Neuropeptides; 1989 Oct; 14(3):191-6. PubMed ID: 2575716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopeptidases: aminopeptidase M (EC 3.4.11.2), pyroglutamate aminopeptidase (EC 3.4.19.3), and prolidase (EC 3.4.13.9).
    Sweeney PJ; Walker JM
    Methods Mol Biol; 1993; 16():319-29. PubMed ID: 19082982
    [No Abstract]   [Full Text] [Related]  

  • 17. Degradation of pyroglutamyl-phenylalanyl-proline amide by a pyroglutamyl aminopeptidase purified from membrane fractions of bovine brain.
    Kelly JA; Loscher CE; Gallagher S; O'Connor B
    Biochem Soc Trans; 1997 Feb; 25(1):114S. PubMed ID: 9057012
    [No Abstract]   [Full Text] [Related]  

  • 18. Homology modeling and site-directed mutagenesis of pyroglutamyl peptidase II. Insights into omega-versus aminopeptidase specificity in the M1 family.
    Chávez-Gutiérrez L; Matta-Camacho E; Osuna J; Horjales E; Joseph-Bravo P; Maigret B; Charli JL
    J Biol Chem; 2006 Jul; 281(27):18581-90. PubMed ID: 16611635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and cytotoxicity of 2-alpha-aminoacyl prodrugs of methotrexate.
    Smal MA; Dong Z; Cheung HT; Asano Y; Escoffier L; Costello M; Tattersall MH
    Biochem Pharmacol; 1995 Feb; 49(4):567-74. PubMed ID: 7872963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloromethyl ketones are insulin-like stimulators of lipid synthesis in locust fat body.
    Lee MJ; Goldsworthy GJ
    Arch Insect Biochem Physiol; 1998; 39(1):9-17. PubMed ID: 9816672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.